Preventing Non-Communicable Diseases Using Pricing Policies: Lessons for the United States from Global Experiences and Local Pilots
- PMID: 35849659
- Bookshelf ID: NBK581960
- DOI: 10.3768/rtipress.2021.pb.0025.2105
Preventing Non-Communicable Diseases Using Pricing Policies: Lessons for the United States from Global Experiences and Local Pilots
Excerpt
Preventing non-communicable diseases (NCDs) in an effective and sustainable way will require forward-looking policy solutions that can address multiple objectives. This was true pre–COVID-19 and is even more true now. There are already examples from across the globe and within the United States that show how these may be possible. Although there are still many unknowns around how the design, targeting, level, sequencing, integration, and implementation of fiscal policies together can maximize their NCD prevention potential, there is already clear evidence that health taxes and particularly sugar-sweetened beverage (SSB) taxes are cost-effective.
Nonetheless, policies alone may not succeed. Political will to prioritize well-being, protections against industry interference, and public buy-in are necessary. If those elements align, pricing policies that consider the context in question can be designed and implemented to achieve several goals around reducing consumption of unhealthy SSBs and foods, narrowing existing nutritional and health disparities, encouraging economic and social development. The US and its local and state jurisdictions should consider these pricing policy issues and their contexts carefully, in collaboration with community partners and researchers, to design multi-duty actions and to be prepared for future windows of opportunities to open for policy passage and implementation.
© 2021 Research Triangle Institute. All rights reserved.
Sections
References
-
- Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al.; GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736–88. 10.1016/S0140-6736(18)32203-7 - DOI - PMC - PubMed
-
- National Academies of Sciences, Engineering, Medicine. The convergence of infectious diseases and noncommunicable diseases: proceedings of a workshop. Washington (DC): The National Academies Press; 2019. - PubMed
Publication types
LinkOut - more resources
Full Text Sources